Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)
Health Sciences at UMB and Bioengineering at UMCP have a rich, collaborative relationship in both research programs and graduate student programs. Major areas of partnership between the School of Pharmacy at UMB and the Fischell Department of Bioengineering at UMCP include jointly taught graduate courses, joint faculty, and research collaborations.
This relationship is strengthened by the Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), a collaborative partnership between the two universities focused on modernizing and improving the ways drugs and medical devices are reviewed and evaluated. Funded by the U.S. Food and Drug Administration (FDA), M-CERSI joins researchers from both campuses with FDA staff to support the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.
In 2018, M-CERSI celebrated the growth of the University of Maryland Master of Science in Regulatory Science.
To learn more: Maryland Center of Excellence in Regulatory Science and Innovation
Read more about M-CERSI and FDA’s AI workshop highlighting future FDA comment period on AI in drug development
